Creatv BIO

CreatvBio has discovered a cancer biomarker containing tumor material in the blood of cancer patients found in high percentages in all stages and in over 20 solid tumors. Utilizing this biomarker, Creatv developed LifeTracDxTM assays for cancer screening, for companion diagnostics to decide therapy, to predict treatment response within 30-60 days of starting therapy, to provide prognosis, and for early detection of cancer recurrence.